SIG
Director Trades
| Date | Director | Value |
|---|---|---|
| 13/2/25 | V. Ramsunder | $34,053,122 |
| 13/2/25 | D. Gance | $120,000,000 |
| 13/4/25 | D. Gance | $297,000,000 |
| 8/5/25 | D. Gance | $382,030,000 |
| 28/5/25 | D. Di Pilla | $94,663,194 |
Company News

Proposed Sigma Healthcare-Chemist Warehouse $8.8b merger gets ACCC green light
The Australian Competition and Consumer Commission (ACCC) has approved a proposed $8.8 billion merger between independent pharmacy network owner Sigma Healthcare (ASX: SIG) and Chemist Warehouse Group. The decision follows a rigorous review process that included extensive public consultation by the ACCC and engagement with both companies. It found the proposed merger would be unlikely […]

Chemist Warehouse and Sigma Healthcare merger to create $8.8 billion ASX powerhouse
In one of the biggest deals seen on the Australian exchange for many years, the Chemist Warehouse Group will arrive as a new listing after merging with Sigma Healthcare. With the combined group valued at around $8.8 billion, it is set for rapid international expansion and will arrive as a top ASX 200 company and […]

Sigma Healthcare beats EBOS to $3b supply contract with Chemist Warehouse
Independent pharmacy network owner Sigma Healthcare (ASX: SIG) has signed a five-year deal to supply Pharmaceutical Benefits Scheme (PBS) medicines and fast-moving consumer goods (FMCG) to retail giant Chemist Warehouse, starting next month. The deal replaces a current supply contract between Chemist Warehouse and Sigma rival EBOS Group (ASX: EBO), which will not be renewed once […]

Huge battle brewing over the future direction of pharmacies in Australia
During the COVID-19 pandemic, a trip to the pharmacy became one of the few shopping highlights that was allowed during the many lockdowns. However, it wasn’t just shoppers who were taking notice of the central role pharmacies play in retailing but also the big companies that own massive chunks of our existing retail chains. Wesfarmers […]

Get bigger or pay money to shareholders – the choice facing companies
It has been a great time to be a shareholder with Australian companies increasingly stuffed with cash which they will now be looking to put to use. Those shareholders may selfishly hope that a lot of that cash will be heading in their direction – either in the form of bumper dividends or share buybacks […]

MedAdvisor expands footprint with Sigma Healthcare as part of ePrescribing revolution
Digital medication company MedAdvisor (ASX: MDR) has further extended its operations within the growing “ePrescribing” market, following a new two-year deal worth around $1 million per year with pharmacy retail group Sigma Healthcare (ASX: SIG). Sigma has over 600 retail pharmacy franchise partners including Amcal, DDS, Guardian, PharmaSave, WholeLife and Chemist King pharmacy brands. MedAdvisor’s role […]